Clinical potential of the HA-1 peptide, a minor histocompatibility antigen

Author：

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.9, Iss.10, 1999-10, pp. : 1437-1441

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection

By Hölscher Christian

CNS Drugs, Vol. 26, Iss. 10, 2012-10 ,pp. : 871-882

Adis International

Access to resources Recommend Favorite

Therapeutic Potential of Peptide Motifs Against HIV-1 Reverse Transcriptase and Integrase

Current Pharmaceutical Design, Vol. 15, Iss. 21, 2009-07 ,pp. : 2508-2519

Bentham Science Publishers

Access to resources Recommend Favorite

“Cancer Antigen WT1 Protein-Derived Peptide”-Based Treatment of Cancer -Toward the Further Development

Current Medicinal Chemistry, Vol. 15, Iss. 29, 2008-12 ,pp. : 3052-3061

Bentham Science Publishers

Access to resources Recommend Favorite

Normal and Pathological Erectile Function The Potential Clinical Role of Endothelin-1 Antagonists

Current Drug Targets, Vol. 1, Iss. 3, 2000-01 ,pp. : 247-260

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs

By Mentlein Rolf

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 1, 2005-01 ,pp. : 57-64

Informa Healthcare

Access to resources Recommend Favorite